<p>Westover Capital Advisors LLC 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第二季度其在 Cardinal Health, Inc.（纽约证券交易所代码：CAH - 免费报告）的持股增加了 75.8%。该基金在此期间购买了额外的 1,837 股后，持有该公司 4,262 股股票。截至其最近的 SEC 备案，Westover Capital Advisors LLC 在 Cardinal Health 的持股价值为 716,000 美元。</p>
<ul>
<li>怀疑市场？3 只股票应对恐惧、不确定性和怀疑</li>
</ul>
<p>其他对冲基金和机构投资者最近也对该公司的持仓进行了调整。Wellington Management Group LLP 在第一季度将其在 Cardinal Health 的股份增加了 1,666.7%。Wellington Management Group LLP 目前拥有 2,384,192 股该公司的股票，价值 328,470,000 美元，此前在上个季度购买了额外的 2,249,241 股。摩根大通（JPMorgan Chase &amp; Co.）在第一季度将其在 Cardinal Health 的股份增加了 40.0%。摩根大通目前拥有 4,175,992 股该公司的股票，价值 575,327,000 美元，此前在上个季度收购了额外的 1,193,983 股。瑞士再保险集团（Zurich Insurance Group Ltd FI）在第一季度将其在 Cardinal Health 的持股增加了 4,935.9%。瑞士再保险集团目前拥有 946,750 股该公司的股票，价值 130,434,000 美元，此前在上个季度收购了额外的 927,950 股。Acadian Asset Management LLC 在第二季度将其在 Cardinal Health 的持仓增加了 92.5%。Acadian Asset Management LLC 目前拥有 1,679,176 股该公司的股票，价值 282,063,000 美元，此前在上个季度购买了额外的 807,063 股。最后，Nuveen LLC 在第一季度购买了 Cardinal Health 的新头寸，价值约 106,065,000 美元。对冲基金和其他机构投资者持有该公司 87.17% 的股票。</p>
<p>获取 <strong>Cardinal Health</strong> 警报：</p>
<h2>分析师升级和降级</h2>
<p>CAH 最近成为几份分析师报告的主题。摩根士丹利（Morgan Stanley）在 8 月 12 日的研究报告中重申了对 Cardinal Health 股票的 “增持” 评级。瑞穗（Mizuho）在 11 月 3 日的报告中将 Cardinal Health 股票的目标价从 170.00 美元上调至 210.00 美元，并给予公司 “跑赢大盘” 的评级。Evercore ISI 在 10 月 31 日的研究报告中将 Cardinal Health 股票的目标价从 190.00 美元上调至 220.00 美元，并给予公司 “跑赢大盘” 的评级。富国银行（Wells Fargo &amp; Company）在 11 月 5 日的研究报告中将 Cardinal Health 的目标价从 185.00 美元上调至 221.00 美元，并给予公司 “增持” 评级。最后，Leerink Partners 在一份报告中将 Cardinal Health 的目标价从 211.00 美元上调至 230.00 美元，并给予该股票 “跑赢大盘” 的评级。十二位股票研究分析师对该股票给予了买入评级，两位给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 206.46 美元。</p>
<ul>
<li>医疗技术股票受益于急性护理需求上升</li>
</ul>
<p><strong>获取我们最新的 CAH 股票分析</strong></p>
<h2>内部人士买卖</h2>
<p>在其他 Cardinal Health 的新闻中，首席执行官 Jason M. Hollar 于 8 月 20 日星期三出售了 35,901 股该股票。该股票的平均售价为 150.04 美元，总价值为 5,386,586.04 美元。交易后，首席执行官持有 200,000 股该公司的股票，价值约 30,008,000 美元。这代表了他们持股的 15.22% 的减少。该交易已在与证券交易委员会的法律文件中披露，可以通过 SEC 网站访问。公司内部人士持有该公司 0.12% 的股票。</p>
<h2>Cardinal Health 股票上涨 0.4%</h2>
<ul>
<li>对于 Cardinal Health，证明将体现在其表现中</li>
</ul>
<p>CAH 周二开盘价为 206.25 美元。该股票的市值为 490 亿美元，市盈率为 31.98，PEG 比率为 1.39，贝塔值为 0.72。该公司有 50 日移动平均价格为 166.70 美元，200 日移动平均价格为 159.64 美元。Cardinal Health, Inc. 的 12 个月低点为 114.60 美元，12 个月高点为 208.32 美元。</p>
<p>Cardinal Health（纽约证券交易所代码：CAH - 获取免费报告）最近于 10 月 30 日星期四发布了其财报。该公司报告本季度每股收益（EPS）为 2.55 美元，超出分析师一致预期的 2.22 美元，超出 0.33 美元。该公司本季度的收入为 640.1 亿美元，而一致预期为 594.1 亿美元。Cardinal Health 的净利润率为 0.70%，股本回报率为负的 74.45%。该公司的收入同比增长 22.4%。在去年同期，该公司发布的每股收益为 1.88 美元。Cardinal Health 已将其 2026 财年的指引设定为每股收益 9.650-9.850 美元。分析师预计 Cardinal Health, Inc. 本年度每股收益为 7.95 美元。</p>
<h2>Cardinal Health 宣布分红</h2>
<p>该公司最近还披露了一项季度分红，将于 1 月 15 日星期四支付。记录在案的投资者将在 1 月 2 日星期五获得 0.5107 美元的分红。该分红的除息日为 1 月 2 日星期五。这代表了 2.04 美元的年化分红和 1.0% 的分红收益率。Cardinal Health 的派息比率目前为 30.77%。</p>
<h2>Cardinal Health 概况</h2>
<p>（免费报告）</p>
<p>Cardinal Health, Inc. 是一家在美国、加拿大、欧洲、亚洲及国际上运营的医疗服务和产品公司。它为医院、医疗系统、药房、门诊手术中心、临床实验室、医生办公室和家庭患者提供定制解决方案。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，而非卡地纳健康</li>
<li>消费者可选消费品股票解析</li>
<li>随着人工智能推动存储需求，希捷股票可能飙升</li>
<li>ETF 筛选器：用途及逐步指南</li>
<li>惠而浦的最坏情况可能已经过去——未来有上涨机会</li>
<li>即将到来的 IPO 股票锁定期解析</li>
<li>这三只被打压的股票可能是你本季度最佳的购买机会</li>
</ul>
<p><strong>想知道其他对卡地纳健康持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取卡地纳健康公司（NYSE:CAH - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在卡地纳健康吗？</h2>
<p>在考虑卡地纳健康之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而卡地纳健康并不在名单上。</p>
<p>虽然卡地纳健康目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

卡地纳健康

<p>Westover Capital Advisors LLC 在第二季度将其在卡地纳健康公司的持股增加了 75.8%，目前拥有 4,262 股，价值 716,000 美元。其他机构投资者也调整了他们的持仓，其中威灵顿管理公司、摩根大通和瑞士再保险的增持幅度显著。分析师对卡地纳健康给予了 “适度买入” 的评级，普遍目标价为 206.46 美元。该股票开盘价为 206.25 美元，市值为 490 亿美元。最近的财报超出预期，收入同比增长 22.4%</p>

<p>Westover Capital Advisors LLC grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 75.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 4,262 shares of the company's stock after purchasing an additional 1,837 shares during the period. Westover Capital Advisors LLC's holdings in Cardinal Health were worth $716,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Westover Capital Advisors LLC 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第二季度其在 Cardinal Health, Inc.（纽约证券交易所代码：CAH - 免费报告）的持股增加了 75.8%。该基金在此期间购买了额外的 1,837 股后，持有该公司 4,262 股股票。截至其最近的 SEC 备案，Westover Capital Advisors LLC 在 Cardinal Health 的持股价值为 716,000 美元。</p>
</div><ul>
<li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li>
</ul>
<div class="lb-trans"><ul>
<li>怀疑市场？3 只股票应对恐惧、不确定性和怀疑</li>
</ul>
</div><p>Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP raised its stake in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after buying an additional 2,249,241 shares during the last quarter. JPMorgan Chase &amp; Co. grew its stake in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase &amp; Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI increased its holdings in shares of Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock valued at $130,434,000 after acquiring an additional 927,950 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company's stock worth $282,063,000 after purchasing an additional 807,063 shares during the last quarter. Finally, Nuveen LLC bought a new position in Cardinal Health in the 1st quarter worth about $106,065,000. Hedge funds and other institutional investors own 87.17% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金和机构投资者最近也对该公司的持仓进行了调整。Wellington Management Group LLP 在第一季度将其在 Cardinal Health 的股份增加了 1,666.7%。Wellington Management Group LLP 目前拥有 2,384,192 股该公司的股票，价值 328,470,000 美元，此前在上个季度购买了额外的 2,249,241 股。摩根大通（JPMorgan Chase &amp; Co.）在第一季度将其在 Cardinal Health 的股份增加了 40.0%。摩根大通目前拥有 4,175,992 股该公司的股票，价值 575,327,000 美元，此前在上个季度收购了额外的 1,193,983 股。瑞士再保险集团（Zurich Insurance Group Ltd FI）在第一季度将其在 Cardinal Health 的持股增加了 4,935.9%。瑞士再保险集团目前拥有 946,750 股该公司的股票，价值 130,434,000 美元，此前在上个季度收购了额外的 927,950 股。Acadian Asset Management LLC 在第二季度将其在 Cardinal Health 的持仓增加了 92.5%。Acadian Asset Management LLC 目前拥有 1,679,176 股该公司的股票，价值 282,063,000 美元，此前在上个季度购买了额外的 807,063 股。最后，Nuveen LLC 在第一季度购买了 Cardinal Health 的新头寸，价值约 106,065,000 美元。对冲基金和其他机构投资者持有该公司 87.17% 的股票。</p>
</div><p>Get <strong>Cardinal Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Cardinal Health</strong> 警报：</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>CAH has been the topic of several recent analyst reports. Morgan Stanley reissued an &#34;overweight&#34; rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Mizuho increased their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the company an &#34;outperform&#34; rating in a report on Monday, November 3rd. Evercore ISI raised their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 31st. Wells Fargo &amp; Company upped their price objective on Cardinal Health from $185.00 to $221.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 5th. Finally, Leerink Partners lifted their target price on Cardinal Health from $211.00 to $230.00 and gave the stock an &#34;outperform&#34; rating in a report on Monday. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $206.46.</p>
<div class="lb-trans"><p>CAH 最近成为几份分析师报告的主题。摩根士丹利（Morgan Stanley）在 8 月 12 日的研究报告中重申了对 Cardinal Health 股票的 “增持” 评级。瑞穗（Mizuho）在 11 月 3 日的报告中将 Cardinal Health 股票的目标价从 170.00 美元上调至 210.00 美元，并给予公司 “跑赢大盘” 的评级。Evercore ISI 在 10 月 31 日的研究报告中将 Cardinal Health 股票的目标价从 190.00 美元上调至 220.00 美元，并给予公司 “跑赢大盘” 的评级。富国银行（Wells Fargo &amp; Company）在 11 月 5 日的研究报告中将 Cardinal Health 的目标价从 185.00 美元上调至 221.00 美元，并给予公司 “增持” 评级。最后，Leerink Partners 在一份报告中将 Cardinal Health 的目标价从 211.00 美元上调至 230.00 美元，并给予该股票 “跑赢大盘” 的评级。十二位股票研究分析师对该股票给予了买入评级，两位给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 206.46 美元。</p>
</div><ul>
<li>Medical Technology Stock Benefits from Rising Acute Care Demand</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗技术股票受益于急性护理需求上升</li>
</ul>
</div><p><strong>Get Our Latest Stock Analysis on CAH</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 CAH 股票分析</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人士买卖</h2>
</div><p>In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the transaction, the chief executive officer owned 200,000 shares of the company's stock, valued at approximately $30,008,000. This represents a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.12% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Cardinal Health 的新闻中，首席执行官 Jason M. Hollar 于 8 月 20 日星期三出售了 35,901 股该股票。该股票的平均售价为 150.04 美元，总价值为 5,386,586.04 美元。交易后，首席执行官持有 200,000 股该公司的股票，价值约 30,008,000 美元。这代表了他们持股的 15.22% 的减少。该交易已在与证券交易委员会的法律文件中披露，可以通过 SEC 网站访问。公司内部人士持有该公司 0.12% 的股票。</p>
</div><h2>Cardinal Health Stock Up 0.4%</h2>
<div class="lb-trans"><h2>Cardinal Health 股票上涨 0.4%</h2>
</div><ul>
<li>For Cardinal Health, the Proof Will be in Its Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>对于 Cardinal Health，证明将体现在其表现中</li>
</ul>
</div><p>CAH opened at $206.25 on Tuesday. The stock has a market capitalization of $49.00 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 1.39 and a beta of 0.72. The firm has a 50 day moving average price of $166.70 and a 200-day moving average price of $159.64. Cardinal Health, Inc. has a twelve month low of $114.60 and a twelve month high of $208.32.</p>
<div class="lb-trans"><p>CAH 周二开盘价为 206.25 美元。该股票的市值为 490 亿美元，市盈率为 31.98，PEG 比率为 1.39，贝塔值为 0.72。该公司有 50 日移动平均价格为 166.70 美元，200 日移动平均价格为 159.64 美元。Cardinal Health, Inc. 的 12 个月低点为 114.60 美元，12 个月高点为 208.32 美元。</p>
</div><p>Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts' consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's revenue was up 22.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.</p>
<div class="lb-trans"><p>Cardinal Health（纽约证券交易所代码：CAH - 获取免费报告）最近于 10 月 30 日星期四发布了其财报。该公司报告本季度每股收益（EPS）为 2.55 美元，超出分析师一致预期的 2.22 美元，超出 0.33 美元。该公司本季度的收入为 640.1 亿美元，而一致预期为 594.1 亿美元。Cardinal Health 的净利润率为 0.70%，股本回报率为负的 74.45%。该公司的收入同比增长 22.4%。在去年同期，该公司发布的每股收益为 1.88 美元。Cardinal Health 已将其 2026 财年的指引设定为每股收益 9.650-9.850 美元。分析师预计 Cardinal Health, Inc. 本年度每股收益为 7.95 美元。</p>
</div><h2>Cardinal Health Announces Dividend</h2>
<div class="lb-trans"><h2>Cardinal Health 宣布分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health's payout ratio is presently 30.77%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度分红，将于 1 月 15 日星期四支付。记录在案的投资者将在 1 月 2 日星期五获得 0.5107 美元的分红。该分红的除息日为 1 月 2 日星期五。这代表了 2.04 美元的年化分红和 1.0% 的分红收益率。Cardinal Health 的派息比率目前为 30.77%。</p>
</div><h2>Cardinal Health Profile</h2>
<div class="lb-trans"><h2>Cardinal Health 概况</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.</p>
<div class="lb-trans"><p>Cardinal Health, Inc. 是一家在美国、加拿大、欧洲、亚洲及国际上运营的医疗服务和产品公司。它为医院、医疗系统、药房、门诊手术中心、临床实验室、医生办公室和家庭患者提供定制解决方案。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Cardinal Health</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>Seagate Stock Could Soar as AI Drives Storage Demand</li>
<li>ETF Screener: Uses and Step-by-Step Guide</li>
<li>Whirlpool’s Worst May Be Over—Upside Opportunity Ahead</li>
<li>Upcoming IPO Stock Lockup Period, Explained</li>
<li>These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而非卡地纳健康</li>
<li>消费者可选消费品股票解析</li>
<li>随着人工智能推动存储需求，希捷股票可能飙升</li>
<li>ETF 筛选器：用途及逐步指南</li>
<li>惠而浦的最坏情况可能已经过去——未来有上涨机会</li>
<li>即将到来的 IPO 股票锁定期解析</li>
<li>这三只被打压的股票可能是你本季度最佳的购买机会</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CAH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对卡地纳健康持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取卡地纳健康公司（NYSE:CAH - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在卡地纳健康吗？</h2>
</div><p>Before you consider Cardinal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑卡地纳健康之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而卡地纳健康并不在名单上。</p>
</div><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然卡地纳健康目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Westover Capital Advisors LLC 收购了卡地纳健康公司（股票代码：$CAH）的 1,837 股股票